Abstract

Neovascularization is a key factor that contributes to tumor metastasis, and vasculogenic mimicry (VM) is an important form of neovascularization found in highly invasive tumors, including lung cancer. Despite the increasing number of studies focusing on VM, the mechanisms underlying VM formation remain unclear. Herein, our study explored the role of the HIF-1α/NRP1 axis in mediating lung adenocarcinoma metastasis and VM formation. HIF-1α, NRP1 expression, and VM in lung adenocarcinoma (LUAD) patient samples were examined by immunohistochemical staining. Quantitative real-time (qRT-PCR), western blot, transwell assay, wound healing assay, and tube formation assay were performed to verify the role of HIF-1α/NRP1 axis in LUAD metastasis and VM formation. ChIP and luciferase reporter assay were used to confirm whether NRP1 is a direct target of HIF-1α. In LUAD tissues, we confirmed a positive relationship between HIF-1α and NRP1 expression. Importantly, high HIF-1α and NRP1 expression and the presence of VM were correlated with poor prognosis. We also found that HIF-1α could induce LUAD cell migration, invasion, and VM formation by regulating NRP1. Moreover, we demonstrated that HIF-1α can directly bind to the NRP1 promoter located between −2009 and −2017 of the promoter. Mechanistically, MMP2, VE-cadherin, and Vimentin expression were affected. HIF-1α plays an important role in inducing lung adenocarcinoma cell metastasis and VM formation via upregulation of NRP1. This study highlights the potential therapeutic value of targeting NRP1 for suppressing lung adenocarcinoma metastasis and progression.

Details

Title
HIF-1α promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment
Author
Fu Ran 1 ; Du Wenwen 2 ; Ding Zongli 3 ; Wang, Yi 3 ; Li, Yue 4 ; Zhu Jianjie 2 ; Zeng Yuanyuan 2 ; Zheng Yulong 3 ; Liu Zeyi 2 ; Jian-an, Huang 2 

 The First Affiliated Hospital of Soochow University, Department of Pulmonary and Critical Care Medicine, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228); Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China (GRID:grid.429222.d); The Affiliated Huai’an Hospital of Xuzhou Medical University, Department of Respiratory Medicine, Huai’an, China (GRID:grid.429222.d) 
 The First Affiliated Hospital of Soochow University, Department of Pulmonary and Critical Care Medicine, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228); Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China (GRID:grid.429222.d); Soochow University, Institute of Respiratory Diseases, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694) 
 The Affiliated Huai’an Hospital of Xuzhou Medical University, Department of Respiratory Medicine, Huai’an, China (GRID:grid.263761.7) 
 The First Affiliated Hospital of Soochow University, Department of Pulmonary and Critical Care Medicine, Suzhou, China (GRID:grid.429222.d) (ISNI:0000 0004 1798 0228); Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China (GRID:grid.429222.d) 
Publication year
2021
Publication date
Apr 2021
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2512157646
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.